Clinical Trial Update: Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 screening study sponsored by Hoffmann-La Roche to identify individuals who may be eligible for Alzheimer's disease trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Alzheimers Disease | Phase 3 | Status: RECRUITING